Profil
Ralph Laufer is currently the Chief Scientific Officer at Lysogene SA since 2018.
Prior to this, he was the Senior Vice President at Teva Pharmaceutical Industries Ltd. from 2013 to 2018.
He was also the Scientific Director at IRBM Science Park SpA from 2001 to 2009 and the Head-Pharmacology at IRBM SpA from 1991 to 2001.
Additionally, he worked as a Director at Immuneering Corp.
Dr. Laufer received his graduate and doctorate degrees from The Hebrew University of Jerusalem.
Aktive Positionen von Ralph Laufer
| Unternehmen | Position | Beginn |
|---|---|---|
| LYSOGENE | Technik-/Wissenschafts-/F&E-Leiter | 02.05.2018 |
Ehemalige bekannte Positionen von Ralph Laufer
| Unternehmen | Position | Ende |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01.04.2018 |
IRBM Science Park SpA
IRBM Science Park SpA Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biomedical products | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2009 |
IRBM SpA
IRBM SpA BiotechnologyHealth Technology Researches and develops new drugs | Corporate Officer/Principal | 01.01.2001 |
| IMMUNEERING CORPORATION | Direktor/Vorstandsmitglied | - |
Ausbildung von Ralph Laufer
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IRBM SpA
IRBM SpA BiotechnologyHealth Technology Researches and develops new drugs | Health Technology |
IRBM Science Park SpA
IRBM Science Park SpA Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biomedical products | Commercial Services |
Immuneering Corp.
Immuneering Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, focuses on the oncology and neuroscience product candidates | Health Technology |
Lysogene SA
Lysogene SA BiotechnologyHealth Technology Engages in research and clinical development of gene therapy for neurodegenerative disorders | Health Technology |
















